American innovation in drug discovery and biotechnology is making us healthier. But an expanding black market for experimental drugs threatens Americans’ safety and national security.
Medicines still in clinical trials are being shipped directly to consumers from unregulated Chinese factories. One example is retatrutide (“reta”), an experimental weight-loss drug that has not received approval from the FDA or any other regulator worldwide.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.